Escalon Medical Gross Margin 2010-2024 | ESMC
Current and historical gross margin for Escalon Medical (ESMC) over the last 10 years. The current gross profit margin for Escalon Medical as of December 31, 2024 is %.
| Escalon Medical Gross Margin Historical Data |
| Date |
TTM Revenue |
TTM Gross Profit |
Gross Margin |
| 2024-12-31 |
$0.01B |
$0.01B |
41.67% |
| 2024-09-30 |
$0.01B |
$0.00B |
33.33% |
| 2024-06-30 |
$0.01B |
$0.00B |
33.33% |
| 2024-03-31 |
$0.01B |
$0.00B |
33.33% |
| 2023-12-31 |
$0.01B |
$0.01B |
41.67% |
| 2023-09-30 |
$0.01B |
$0.01B |
41.67% |
| 2023-06-30 |
$0.01B |
$0.01B |
41.67% |
| 2023-03-31 |
$0.01B |
$0.01B |
41.67% |
| 2022-12-31 |
$0.01B |
$0.00B |
36.36% |
| 2022-09-30 |
$0.01B |
$0.00B |
36.36% |
| 2022-06-30 |
$0.01B |
$0.00B |
36.36% |
| 2022-03-31 |
$0.01B |
$0.00B |
36.36% |
| 2021-12-31 |
$0.01B |
$0.00B |
36.36% |
| 2021-09-30 |
$0.01B |
$0.00B |
36.36% |
| 2021-06-30 |
$0.01B |
$0.00B |
40.00% |
| 2021-03-31 |
$0.01B |
$0.00B |
44.44% |
| 2020-12-31 |
$0.01B |
$0.00B |
44.44% |
| 2020-09-30 |
$0.01B |
$0.00B |
44.44% |
| 2020-06-30 |
$0.01B |
$0.00B |
44.44% |
| 2020-03-31 |
$0.01B |
$0.00B |
44.44% |
| 2019-12-31 |
$0.01B |
$0.00B |
40.00% |
| 2019-09-30 |
$0.01B |
$0.00B |
44.44% |
| 2019-06-30 |
$0.01B |
$0.00B |
44.44% |
| 2019-03-31 |
$0.01B |
$0.00B |
40.00% |
| 2018-12-31 |
$0.01B |
$0.00B |
40.00% |
| 2018-09-30 |
$0.01B |
$0.01B |
45.45% |
| 2018-06-30 |
$0.01B |
$0.01B |
41.67% |
| 2018-03-31 |
$0.01B |
$0.01B |
41.67% |
| 2017-12-31 |
$0.01B |
$0.01B |
41.67% |
| 2017-09-30 |
$0.01B |
$0.00B |
33.33% |
| 2017-06-30 |
$0.01B |
$0.00B |
36.36% |
| 2017-03-31 |
$0.01B |
$0.00B |
36.36% |
| 2016-12-31 |
$0.01B |
$0.01B |
45.45% |
| 2016-09-30 |
$0.01B |
$0.01B |
45.45% |
| 2016-06-30 |
$0.01B |
$0.01B |
41.67% |
| 2016-03-31 |
$0.01B |
$0.01B |
41.67% |
| 2015-12-31 |
$0.01B |
$0.01B |
41.67% |
| 2015-09-30 |
$0.01B |
$0.01B |
46.15% |
| 2015-06-30 |
$0.01B |
$0.01B |
46.15% |
| 2015-03-31 |
$0.01B |
$0.01B |
46.15% |
| 2014-12-31 |
$0.01B |
$0.01B |
46.15% |
| 2014-09-30 |
$0.01B |
$0.01B |
50.00% |
| 2014-06-30 |
$0.01B |
$0.01B |
58.33% |
| 2014-03-31 |
$0.01B |
$0.01B |
58.33% |
| 2013-12-31 |
$0.01B |
$0.01B |
50.00% |
| 2013-09-30 |
$0.01B |
$0.01B |
46.15% |
| 2013-06-30 |
$0.01B |
$0.01B |
41.67% |
| 2013-03-31 |
$0.01B |
$0.01B |
41.67% |
| 2012-12-31 |
$0.01B |
$0.01B |
50.00% |
| 2012-09-30 |
$0.01B |
$0.01B |
54.55% |
| 2012-06-30 |
$0.01B |
$0.01B |
54.55% |
| 2012-03-31 |
$0.01B |
$0.01B |
38.46% |
| 2011-12-31 |
$0.02B |
$0.01B |
31.25% |
| 2011-09-30 |
$0.02B |
$0.01B |
25.00% |
| 2011-06-30 |
$0.03B |
$0.01B |
28.00% |
| 2011-03-31 |
$0.03B |
$0.01B |
39.29% |
| 2010-12-31 |
$0.03B |
$0.01B |
40.00% |
| 2010-09-30 |
$0.03B |
$0.01B |
45.16% |
| 2010-06-30 |
$0.03B |
$0.01B |
43.75% |
| 2010-03-31 |
$0.03B |
$0.01B |
37.93% |
| 2009-12-31 |
$0.03B |
$0.01B |
40.00% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED/DENTAL-SUPP |
$0.001B |
$0.012B |
|
Escalon Medical Corp. develops, markets and distributes ophthalmic diagnostic, surgical and pharmaceutical products as well as vascular access devices. The company utilizes strategic partnerships to help finance its development programs and is also seeking acquisitions to further diversify its product line to achieve critical mass in sales and take better advantage of the company's distribution capabilities.
|
